Dr. Ann M. Geiger is the Scientific Director of Cancer Care Delivery Research in the NCI Community Oncology Research Program, where she leads trans-NCI efforts to develop a robust portfolio of pragmatic trials across approximately 1,000 oncology practices in the United States, with the ultimate goal of improving outcomes for cancer patients and survivors who receive care in the community. She previously served as Acting Associate Director, and then the permanent Deputy Associate Director, of the newly formed Healthcare Delivery Research Program, with responsibility for developing a scientific vision, establishing efficient operations, and nurturing a collegial culture for this new group. In addition, Dr. Geiger was previously Chief of the Healthcare Assessment Research Branch and was responsible for a grant portfolio and research initiatives aimed at addressing questions related to access, utilization, diffusion, and outcome of health care in populations. Her mentoring efforts in these leadership roles were recognized by a NCI Director’s Award in 2019. Dr. Geiger has participated in several national initiatives, including currently serving as the Quality of Life Co-Chair for the NCI COVID-19 in Cancer Patients Study, for which she and key collaborators in developing the study received a 2021 NIH Director’s Award.
Before joining NCI, Dr. Geiger worked in both academic and delivery system settings. She spent seven years on the faculty of Wake Forest University School of Medicine where, in addition to conducting research focused on cancer survivorship, she served as Co-Director of the Graduate Program in Clinical and Translational Sciences. Prior to her position at Wake Forest, Dr. Geiger was a scientist at Kaiser Permanente Southern California for ten years, where she collaborated with clinicians and institutional leaders to conduct practice-based research focused on cancer screening, treatment outcomes, and quality of life. She has co-authored over 120 publications and participated in numerous peer reviews of manuscripts and grant applications, as well as serving as an Associate Editor of the Journal of the National Cancer Institute since 2007. Dr. Geiger earned an A.B. in Biology from Harvard-Radcliffe College and a M.P.H. and Ph.D. in Epidemiologic Science from the University of Michigan.